BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3574693)

  • 1. Phenelzine toxicity responsive to dantrolene.
    Verrilli MR; Salanga VD; Kozachuk WE; Bennetts M
    Neurology; 1987 May; 37(5):865-7. PubMed ID: 3574693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenelzine overdose treated with dantrolene sodium.
    Kaplan RF; Feinglass NG; Webster W; Mudra S
    JAMA; 1986 Feb; 255(5):642-4. PubMed ID: 3944965
    [No Abstract]   [Full Text] [Related]  

  • 3. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s.
    Dawson JK; Earnshaw SM; Graham CS
    J Accid Emerg Med; 1995 Mar; 12(1):49-51. PubMed ID: 7640830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pretreatment with a monoamine oxidase inhibitor (phenelzine) on the effects of buprenorphine and pethidine in the conscious rabbit.
    Mackenzie JE; Frank LW
    Br J Anaesth; 1988 Feb; 60(2):216-21. PubMed ID: 3345281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed excitatory reaction following interaction of cocaine and monoamine oxidase inhibitor (phenelzine).
    Tordoff SG; Stubbing JF; Linter SP
    Br J Anaesth; 1991 Apr; 66(4):516-8. PubMed ID: 2025483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitor overdose.
    Linden CH; Rumack BH; Strehlke C
    Ann Emerg Med; 1984 Dec; 13(12):1137-44. PubMed ID: 6391305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin syndrome probably triggered by a morphine-phenelzine interaction.
    Mateo-Carrasco H; Muñoz-Aguilera EM; García-Torrecillas JM; Abu Al-Robb H
    Pharmacotherapy; 2015 Jun; 35(6):e102-5. PubMed ID: 25903219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocarditis after massive phenelzine overdose.
    Waring WS; Wallace WA
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1007-9. PubMed ID: 17823790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
    Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
    Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Ping-pong" gaze in severe monoamine oxidase inhibitor toxicity.
    Erich JL; Shih RD; O'Connor RE
    J Emerg Med; 1995; 13(5):653-5. PubMed ID: 8530785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of phenelzine-induced hypotension with salt tablets: case report.
    Munjack DJ
    J Clin Psychiatry; 1984 Feb; 45(2):89-90. PubMed ID: 6693369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism induced by a monoamine oxidase inhibitor.
    Gillman MA; Sandyk R
    Postgrad Med J; 1986 Mar; 62(725):235-6. PubMed ID: 3714615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    Magistris F; Gamble J
    A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.
    Smith SE; Lambourn J; Tyrer PJ
    Br J Clin Pharmacol; 1980 Jan; 9(1):21-5. PubMed ID: 7356888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    Teusink JP; Alexopoulos GS; Shamoian CA
    Am J Psychiatry; 1984 Jan; 141(1):118-9. PubMed ID: 6691428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    Thomas JM; Rubin EH
    Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.